These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
24. Galantamine: a review of its use in Alzheimer's disease and vascular dementia. Corey-Bloom J Int J Clin Pract; 2003 Apr; 57(3):219-23. PubMed ID: 12723727 [TBL] [Abstract][Full Text] [Related]
27. Propentofylline treatment for Alzheimer disease and vascular dementia: an economic evaluation based on functional abilities. Bachynsky J; McCracken P; Lier D; Alloul K; Jacobs P Alzheimer Dis Assoc Disord; 2000; 14(2):102-11. PubMed ID: 10850749 [TBL] [Abstract][Full Text] [Related]
28. [Modern therapy for dementia]. Padberg F; Möller HJ; Bottlender R; Hampel H MMW Fortschr Med; 2005 May; 147 Spec No 2():71-4, 76-7. PubMed ID: 15968877 [TBL] [Abstract][Full Text] [Related]
29. Bifunctional drug derivatives of MAO-B inhibitor rasagiline and iron chelator VK-28 as a more effective approach to treatment of brain ageing and ageing neurodegenerative diseases. Youdim MB; Fridkin M; Zheng H Mech Ageing Dev; 2005 Feb; 126(2):317-26. PubMed ID: 15621213 [TBL] [Abstract][Full Text] [Related]
30. Mounting a defence against Alzheimer's disease. Ross M CMAJ; 1999 Mar; 160(6):773. PubMed ID: 10189410 [No Abstract] [Full Text] [Related]
31. [Can better antihypertensive treatment prevent dementia? A question under investigation]. Kilander L Lakartidningen; 1999 Dec; 96(48):5357-60. PubMed ID: 10612985 [No Abstract] [Full Text] [Related]
32. The pharmacological rationale for treating vascular dementia with galantamine (Reminyl). Maelicke A Int J Clin Pract Suppl; 2001 May; (120):24-8. PubMed ID: 11406923 [TBL] [Abstract][Full Text] [Related]
33. [Dementing disorders. What benefits do the new anti-dementia drugs have?]. Ihl R MMW Fortschr Med; 2002 May; Suppl 2():24-6, 28-9. PubMed ID: 12070846 [TBL] [Abstract][Full Text] [Related]
34. [Therapy of primary dementia based on modern concepts]. Nervenarzt; 1995 May; 66(5 Suppl):1-4. PubMed ID: 9131089 [No Abstract] [Full Text] [Related]
35. [The clinical relevance of memantine use]. Sobów T Psychiatr Pol; 2004; 38(2):321-30. PubMed ID: 15307296 [TBL] [Abstract][Full Text] [Related]
36. Galantamine: use in Alzheimer's disease and related disorders. Bullock R Expert Rev Neurother; 2004 Mar; 4(2):153-63. PubMed ID: 15853556 [TBL] [Abstract][Full Text] [Related]
37. Effect of non-steroidal anti-inflammatory drugs on natural killer cell activity in patients with dementia. Aizen E; Kagan G; Assy B; Iobel R; Bershadsky Y; Gilhar A Isr Med Assoc J; 2005 Feb; 7(2):78-81. PubMed ID: 15729955 [TBL] [Abstract][Full Text] [Related]
38. Antipsychotic treatment of psychosis and agitation in the elderly. Daniel DG J Clin Psychiatry; 2000; 61 Suppl 14():49-52. PubMed ID: 11154017 [TBL] [Abstract][Full Text] [Related]
39. [The importance of nimodipine in treatment of dementia]. Eckert A Pharm Unserer Zeit; 2005; 34(5):392-8. PubMed ID: 16180362 [No Abstract] [Full Text] [Related]
40. Treatment update in geriatric psychiatry. Schneiber LS West J Med; 1998 Jul; 169(1):42-3. PubMed ID: 9682632 [No Abstract] [Full Text] [Related] [Previous] [Next] [New Search]